CLEOPATRA: a phase III evaluation of pertuzumab and trastuzumab for HER2-positive metastatic breast cancer by Baselga José, Swain Sandra M in Clinical breast cancer (2010).

[PMID: 21147694] PubMed

Abstract

Discussed In Paper

Loading...

Dosing Information

No dosing information annotated.